Abstract:Objective To explore the role of IL-23 and IL-17 on bronchial asthma. Methods Thirty female BALB/c mice were randomly divided into 3 group (n=10): asthma model (group A), corticosteroid treatment group (group B) and normal control group (group C). All mice were killed 24 h after final OVA challenge. Blood was obtained for measurements of serum IL-17, IFN-γ and IL-23 by ELISA. Bronchoalveolar lavage fluid (BALF) was collected for eosinophil (EOS) count. The left lung was isolated for pathological examination. Lung sections were stained with hematoxylin and eosin (HE). The mRNA expressions of IL-17 and IL-23 in lung tissue were measured by RT-PCR. Results The mouse asthma model appeared ethology change specific to asthma, EOS count increase in BALF and typical pathological change in lung tissue. The BALF EOS count [(45.5±2.1)×10^7L^(-1)], the concentrations of serum IL-17 and IL-23 [(94.42±3.41)ng•L^(-1) and (155.56±12.5)ng•L^(-1)] and mRNA expressions of IL-17 and IL-23 in group A were significantly higher than those in group C, while the concentration of serum IFN-γ [(20.91±1.59)ng•L^(-1)] in group A was significantly lower than that in group C (P(subscript a)＜0.01).There were positive correlations between the concentrations of serum IL-23 and IL-17(r=0.763, P＜0.05) and between the mRNA expressions of IL-17 and IL-23(r=0.628, P＜0.05), but both the concentrations of IL-23 and IL-17 had no correlation with IFN-γ. There was a positive correlation between the expression of IL-17 in lung and the BALF EOS count (r=0.849, P＜0.01), while the expression of IL-23 had no correlation with the BALF EOS count. In group B, the BALF EOS count [(16.4±1.7)×10^7L^(-1)], the concentrations of serum IL-17 and IL-23 [(56.01±3.92)ng•L^(-1) and (88.00±6.43)ng•L^(-1)] and the mRNA expressions of IL-17 and IL-23 were significantly lower than those in group A, while the concentration of serum IFN-γ [(31.66±1.29)ng•L^(-1)] was significantly higher than that in group A(P(subscript a)＜0.01). Conclusions The IL-23 and IL-17 levels with increased concentrations in serum and mRNA expression in asthmatic mouse lung might be involved in the pathogenesis of bronchial asthma, and could be inhibited by inhaled glucocorticoid. IL-17 might contribute to the increase of EOS in asthma and IL-23 might contribute to the development of asthma indirectly by inducing IL-17 generation.

Blockade of IL-23 Ameliorates Allergic Lung Inflammation Via Decreasing the Infiltration of Tc17 Cells.

Effect of Interleukin-23 and Interleukin-17 on Bronchial Asthma in Mice

IL-23 Signaling Enhances Th2 Polarization and Regulates Allergic Airway Inflammation

Interleukin-17 Orchestrates the Granulocyte Influx into Airways after Allergen Inhalation in A Mouse Model of Allergic Asthma

Il-25 Promotes Th2 Immunity Responses In Asthmatic Mice Via Nuocytes Activation

A new Anticalin protein for IL-23 inhibits non-type 2 allergen-driven mouse lung inflammation and airway hyperresponsiveness

Preventative Tracheal Administration of Interleukin-27 Attenuates Allergic Asthma by Improving the Lung Th1 Microenvironment

IL-25 Promotes Th2 Immunity Responses in Airway Inflammation of Asthmatic Mice Via Activation of Dendritic Cells

The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma

Cd4(+)Cd25(+) Regulatory T Cells Decreased Cd8(+)Il-4(+) Cells In A Mouse Model Of Allergic Asthma

Enhanced Local Foxp3 Expression in Lung Tissue Attenuates Airway Inflammation in A Mouse Model of Asthma

Interleukin-22 attenuates allergic airway inflammation in ovalbumin-induced asthma mouse model

Interleukin-17 is a negative regulator of established allergic asthma.

The expression of interleukin 23(IL-23) in model of asthmatic mice

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

Change of Interleukin-23 Level in Mouse Asthma Model and Its Action Mechanism

Increased IL-4- and IL-17-producing CD8 + cells are related to decreased CD39 + CD4 + Foxp3 + cells in allergic asthma.

The Study of the Ratio and Distribution of Th17 Cells and Tc17 Cells in Asthmatic Patients and the Mouse Model

Mechanisms of pathogenesis in allergic asthma: role of interleukin-23.

IL-27 Alleviates Airway Inflammation and Airway Hyperresponsiveness in Asthmatic Mice by Targeting the CD39/ATP Axis of Dendritic Cells

Ccl2/Ccr2-Dependent Recruitment of Th17 Cells but Not Tc17 Cells to the Lung in A Murine Asthma Model